HYDROXYLATION OF ANTI-TUMOR AGENT, ELLIPTICINE, BY LIVER-MICROSOMES FROM DIFFERENTLY PRETREATED RATS

被引：50

作者：

LESCA, P

LECOINTE, P

PAOLETTI, C

MANSUY, D

机构：

[1] CNRS, PHARMACOL & TOXICOL FUNDAMENTALES LAB, F-31078 TOULOUSE, FRANCE

[2] ECOLE NORM SUPER, CNRS, CHIM LAB 32, F-75231 PARIS 5, FRANCE

来源：

BIOCHEMICAL PHARMACOLOGY | 1977年 / 26卷 / 22期

关键词：

D O I：

10.1016/0006-2952(77)90270-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2169 / 2173

页数：5

共 29 条

[11]

ESTABROOK R W, 1972, P159

[12]

HARVESTY CT, 1972, CANCER RES, V32, P1884

[13] INFLUENCE OF PYRIDINE AND SOME PYRIDINE-DERIVATIVES ON SPECTRAL PROPERTIES OF REDUCED MICROSOMES AND ON MICROSOMAL DRUG-METABOLIZING ACTIVITY [J].

JONEN, HG ;

HUTHWOHL, B ;

KAHL, R ;

KAHL, GF .

BIOCHEMICAL PHARMACOLOGY, 1974, 23 (08) :1319-1329

[14] NEW ANTITUMORAL AGENT - 9-HYDROXYELLIPTICINE - POSSIBILITY OF A RATIONAL DESIGN OF ANTI-CANCEROUS DRUGS IN SERIES OF DNA INTERCALATING DRUGS [J].

LEPECQ, JB ;

NGUYENDANGHUNG ;

GOSSE, C ;

PAOLETTI, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) :5078-5082

[15]

LEPECQ JB, 1976, CANCER RES, V36, P3067

[16]

LESCA P, 1976, CR ACAD SCI D NAT, V282, P1457

[17]

LESCA P, TO BE PUBLISHED

[18]

LOO TL, 1975, PHARMACOL BASIS, P57

[19]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[20]

MANNERING GJ, 1972, FUNDAMENTALS DRUG ME, P206

← 1 2 3 →